Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,484 public trials 1,154 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

Effects of Exemestane on Bone Strength

NCT01144468

Conditions
Bone Diseases, Bone Diseases, Metabolic, Breast Cancer, +10 more
Locations
  • University of California Davis Sacramento, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University Health Network, TGH Toronto, Ontario, Canada
  • Women's College Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

NCT00003782

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 157 locations
View Trial Details
Completed

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hospital of Guessing Guessing, Burgenland, Austria
  • Hospital Oberpullendorf Oberpullendorf, Burgenland, Austria
  • Hospital Oberwart Oberwart, Burgenland, Austria
  • State Hospital Klagenfurt, Surgery Klagenfurt, Carinthia, Austria
View all 72 locations
View Trial Details
Completed

Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer

NCT05112536

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Santa Monica, California, United States
  • PIH Health Whittier, California, United States
  • Nebraska Hematology-Oncology, P.C. Lincoln, Nebraska, United States
View Trial Details

Related conditions